(Rac) -PAT-494
(Rac) -PAT-494 is a type II autotaxin inhibitor with the activity of inhibiting the production of lysophosphatidic acid (LPA) in the blood. (Rac) -PAT-494 can participate in the inhibition of diseases related to cancer, fibrosis and inflammation by antagonizing the function of autotaxin. (Rac) -PAT-494 shows high activity in biochemical and plasma tests. (Rac) -PAT-494 can reduce plasma LPA levels after oral administration to rats[1].
Product Specifications
CAS Number
[1781233-72-4]
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rac-pat-494.html
Smiles
FC1=CC=C(CN2C3=CC=CC=C3C4=C2CN(C5C4)C(NC5=O)=O)C=C1
Molecular Formula
C20H16FN3O2
Molecular Weight
349.36
References & Citations
[1]Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
NPSR1, CT (NPSR1, GPR154, GPRA, PGR14, Neuropeptide S receptor, G-protein coupled receptor 154, G-protein coupled receptor PGR14, G-protein coupled receptor for asthma susceptibility) (MaxLight 750)
NPSR1, CT (NPSR1, GPR154, GPRA, PGR14, Neuropeptide S receptor, G-protein coupled receptor 154, G-protein coupled receptor PGR14, G-protein coupled receptor for asthma susceptibility) (MaxLight 750)
